444 related articles for article (PubMed ID: 27091837)
1. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
Michelsen B; Diamantopoulos AP; Hammer HB; Soldal DM; Kavanaugh A; Haugeberg G
Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
[TBL] [Abstract][Full Text] [Related]
2. Disparity between ultrasound and clinical findings in psoriatic arthritis.
Husic R; Gretler J; Felber A; Graninger WB; Duftner C; Hermann J; Dejaco C
Ann Rheum Dis; 2014 Aug; 73(8):1529-36. PubMed ID: 23740228
[TBL] [Abstract][Full Text] [Related]
3. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
4. Evaluating current definitions of low disease activity in psoriatic arthritis using ultrasound.
Bosch P; Husic R; Ficjan A; Gretler J; Lackner A; Graninger WB; Duftner C; Hermann J; Dejaco C
Rheumatology (Oxford); 2019 Dec; 58(12):2212-2220. PubMed ID: 31199483
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
Lubrano E; De Socio A; Perrotta FM
J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
[TBL] [Abstract][Full Text] [Related]
6. Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia.
Polachek A; Furer V; Zureik M; Nevo S; Mendel L; Levartovsky D; Wollman J; Aloush V; Tzemach R; Elalouf O; Anouk M; Berman M; Kaufman I; Carmi O; Lahat Y; Eviatar T; Padova H; Sarbagil-Maman H; Borok S; Broyde A; Eder L; Paran D; Elkayam O
Ann Rheum Dis; 2021 Dec; 80(12):1553-1558. PubMed ID: 34215648
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score).
Ficjan A; Husic R; Gretler J; Lackner A; Graninger WB; Gutierrez M; Duftner C; Hermann J; Dejaco C
Arthritis Res Ther; 2014 Oct; 16(5):476. PubMed ID: 25361855
[TBL] [Abstract][Full Text] [Related]
8. Comparison of disease activity measures in early psoriatic arthritis in usual care.
Wervers K; Luime JJ; Tchetverikov I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Vis M;
Rheumatology (Oxford); 2019 Dec; 58(12):2251-2259. PubMed ID: 31211399
[TBL] [Abstract][Full Text] [Related]
9. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Gutierrez M
Biomed Res Int; 2014; 2014():528105. PubMed ID: 24967375
[TBL] [Abstract][Full Text] [Related]
10. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
[TBL] [Abstract][Full Text] [Related]
11. Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol.
Canzoni M; Piga M; Zabotti A; Scirè CA; Carrara G; Olivieri I; Iagnocco A
BMJ Open; 2018 Jul; 8(7):e021942. PubMed ID: 29991631
[TBL] [Abstract][Full Text] [Related]
12. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
Lubrano E; Parsons WJ; Perrotta FM
J Rheumatol; 2016 May; 43(5):918-23. PubMed ID: 26980581
[TBL] [Abstract][Full Text] [Related]
14. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.
Helliwell PS; Deodhar A; Gottlieb AB; Boehncke WH; Xu XL; Xu S; Wang Y; Hsia EC; Gladman DD; Ritchlin CT
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1579-1588. PubMed ID: 31421033
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Composite Measure Remission Targets in Psoriatic Arthritis.
Farkas F; Ikumi N; Elmamoun M; Szentpetery A; FitzGerald O
J Rheumatol; 2021 Aug; 48(8):1272-1278. PubMed ID: 33722944
[TBL] [Abstract][Full Text] [Related]
16. Patients with Psoriatic Arthritis Fulfilling the Minimal Disease Activity Criteria Do Not Have Swollen and Tender Joints, but Have Active Skin.
Marin J; Acosta Felquer ML; Ferreyra Garrot L; Ruta S; Rosa J; Soriano ER
J Rheumatol; 2016 May; 43(5):907-10. PubMed ID: 26932341
[TBL] [Abstract][Full Text] [Related]
17. DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs.
Pukšić S; Bolton-King P; Sexton J; Michelsen B; Kvien TK; Berner Hammer H
RMD Open; 2018; 4(2):e000765. PubMed ID: 30487999
[TBL] [Abstract][Full Text] [Related]
18. Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments.
Coates LC; Helliwell PS
J Rheumatol; 2016 Feb; 43(2):371-5. PubMed ID: 26669918
[TBL] [Abstract][Full Text] [Related]
19. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
20. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
Perrotta FM; Marchesoni A; Lubrano E
J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]